Agilent Technologies Authorizes New Share Repurchase Program and Increases Quarterly Dividend

Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has authorized the repurchase of up to $500 million of the company's common stock during fiscal 2013. The new repurchase authorization replaces Agilent's existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs. The [...]

Pall Corporation Board of Directors Declares Dividend and Increases Share Repurchase Authorization

PORT WASHINGTON, N.Y., - Pall Corporation (NYSE:PLL) today announced that its board of directors declared a quarterly dividend of 25 cents per share. The dividend is payable on February 22, 2013 to shareholders of record on the close of business on February 8, 2013. The board also increased the company's authorization to repurchase shares of [...]

Cellular Dynamics Announces the Production of Human iPSC Lines Under cGMP Conditions

MADISON, WIS., –Cellular Dynamics International, Inc. (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells for drug discovery and safety, today announced that it is producing human iPSC master cell banks from five individual donors under current Good Manufacturing Practices (cGMPs). Manufacturing human iPSCs and ultimately human cells [...]

Biologically Intelligent Database Searching for Lead Identification and Patent Fortification

Welwyn Garden City, UK –– Cresset, innovative provider of chemistry software and services, announces the completion of its Cresset proV10 suite with the relaunch of its highly successful FieldScreen system as blazeV10 for ligand based virtual screening. blazeV10 uses the shape and electrostatic character of known ligands to rapidly search large chemical collections for molecules [...]

INTEGRA Biosciences Announces French Subsidiary

Following the 2012 acquisition of their long time French distribution partner - Valdea Biosciences SAS – INTEGRA Biosciences has announced, as of 4th January 2013, that all its operations in France will trade as INTEGRA Biosciences SAS (St Ouen l'Aumône, France). Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences SAS has [...]

Emerson to apply Ovation™ technology at first U.S. commercial-scale solar power facility with fully integrated energy storage

PITTSBURGH — Emerson Process Management has been awarded a contract to apply its Ovation™ expert control system at the Crescent Dunes Solar Energy Project near Tonopah, Nevada. When it comes online at the end of 2013, this 110-MW concentrated solar power (CSP) project will be the first commercial-scale solar facility in the U.S. to generate [...]

New England Biolabs’ New Website Adds Technical Information, Easy Ordering, and Better Search

Ipswich, MA – New England Biolabs (NEB), winner of the 2011 Life Science Industry Awards “Most Useful Website”, is pleased to announce the launch of its new website. Working closely with its customers, NEB set about renovating www.neb.com to make it even more useful and user-friendly for technical support and quick online ordering. “For many [...]

New Advanced High End Brix Refractometer

Farmingdale, NY -- NSG Precision Cellsis proud to reveal their new advanced high-end Brix refractometer, an indispensable device for today’s researcher and industrialist. Brix refractometers are for measuring sucrose concentrations in aqueous solutions. They are primarily used in wine making, the carbonated beverage industry, fruit juice and the starch and sugar industry. The brix refractometer [...]

PLEXERA® LLC Launches Contract Research Services Business for Biomolecular Interaction Studies

Seattle Washington -- Plexera®, LLC, a worldwide provider of label-free surface plasmon resonance imaging (SPRi) technology solutions for functional proteomics, announced today the official launch of its contract research effort based in offices of Plexera LLC located at the Institute for Systems Biology (ISB). Plexera will perform advanced kinetic interaction analysis on either customer provided [...]

Implant Sciences Receives TSA Approval

WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has notified the Company that its Quantum Sniffer™ QS-B220 Explosives Trace Detector has successfully met the requirements for acceptance onto the Air Cargo Screening [...]

Access IBO on Knowledge Center